On day 1, GLP-1 was infused to stimulate endogenous insulin release and suppress endogenous glucagon. On days 2–5, pancreatic endocrine clamps were performed using somatostatin infusions of ...
News Medical on MSN2d
Diabetes drugs may boost brain health but experts warn of risksRAs, originally for diabetes, may impact brain health, finding potential benefits for dementia and addiction but inconsistent ...
FDA approves third insulin biosimilar Merilog to ease U.S. supply shortage FDAs latest insulin biosimilar approval aims to mitigate ongoing supply challenges in the U.S.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback